MEET TOP FDA DECISION AND POLICY MAKERS AT PHARMASALON’S ‘COMPOUNDING PHARMACIES: ACHIEVING QUALITY THROUGH PROCESS AND PROCEDURES’ LIVE-STREAM SALON AUGUST 18-20
Gail Bormel, Acting Associate Director, FDA/CDER Analyst Gabrielle Cosel; and FDA/CDER Division Director Ian Deveau highlight keynote sessions at must-login virtual conference
Los Angeles, California, USA, July 24, 2020 — The FDA’s leading compounding pharmacy voices will lead the keynotes when PharmaSalon convenes its first annual livestream salon, “Compounding Pharmacies: Achieving Quality Through Process and Procedures, August 18-20, 2020.
Gail Bormel, Associate Director for Compounding for the Federal Drug Administration, will kick off the virtual event that will also include FDA Policy Analyst Gabrielle Cosel and Ian Deveau, Division Director for the FDA’s Center for Drug Evaluation Center (CDER).
Attending pharmacists and technicians can earn up to 12 ACPE credits.
Founded by veteran industry events producer Vivian Juter Frankel, PharmaSalon is a leading disrupter of didactic trade show events, reinventing and revitalizing crucial peer-to-peer conversation and idea exchange in an exciting, convenient, cost-effective—and most of all, safe—way.
Other Featured Speakers:
- Rachael Pontikes, Partner, Reed Smith LLC
- Robert B. MacArthur, PharmD, MS, BCSCP, Director of Pharmacy, The Rockefeller University Hospital
- Lee Rosebush, Partner, BakerHostetler
- Versha Gaitonde, Director of Pharmacy Services, QuVa Pharma
- Alexander Pytlarz, Pharmasist, President of Operations, Infuserve, America
- Helen E McKnight, PharmaD, MBA, BCSCP, Director of Pharmacy, Princeton Baptist Medical Center, Department of Pharmacy.
For a complete list of speakers, visit www.pharmasalon.com/speakers
Events will take place 12 p.m. – 4:30 p.m. EST.
The event will have three tracks: 503A, 503B and Hospital Pharmacies.
Each track and day will feature a mix of topics, which will include:
- The role of Compounding Pharmacies post pandemic: capabilities, liabilities and emergency response to pandemics and epidemics.
- How can the current 503B role be expanded post-COVID?
- The industry response to COVID-19
- Managing the post-COVID workforce
- Review Best Practices for Stability Testing and Beyond Use Dating.
PharmaSalon’s first Compounding Pharmacies salon is rethinking traditional and virtual conferences. The salon is s a curated program of thought-provoking round tables, action-packed panel discussions as well as compelling PowerPoint decks. By revising the traditional conference format, to a more discussion-based salon attendees gain expanded perspective and understanding of industry-wide challenges—and the solutions their peers have developed and deployed to meet them. The ROI can be immediate. The perceptive and insights are forever.
For the price of one $799 registration, you can provide login access to this virtual idea exchange your entire working group. Hospital staff attend free.
For more information, visit www.pharmasalon.com/compounding
About PharmaSalon
In the salon tradition of intellectual curiosity, discussion and debate, PharmaSalon is a series of topical executive forums that stimulate solutions through in-depth peer-to-peer dialogue. PharmaSalon was started with the belief that we can move away from didactic and tradeshow formats and create a more engaging event that fosters deeper learning and relationships amongst industry peers.
###
